Literature DB >> 13566461

Relation of hemorrhage and thrombosis to prothrombin during treatment with coumarin-type anticoagulants.

H S SISE, S M LAVELLE, D ADAMIS, R BECKER.   

Abstract

Entities:  

Keywords:  COUMARIN/injurious effects; HEMORRHAGE/etiology and pathogenesis; PROTHROMBIN TIME/effect of drugs on; THROMBOSIS/etiology and pathogenesis

Mesh：

Substances：

Year:  1958        PMID： 13566461     DOI： 10.1056/NEJM195808072590603

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  THE EFFECT OF LANTHANIDES AND ACTINIDES ON BLOOD COAGULATION. II. ASSAY OF A NEW SERUM THROMBOPLASTIC FACTOR VULNERABLE TO THESE ELEMENTS AND ITS VARIATIONS IN HEALTH AND DISEASE.

Authors:  R COLMAN; B ALEXANDER
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

2.  LABORATORY STUDIES ON PATIENTS RECEIVING ANTICOAGULANT THERAPY.

Authors:  S SHAW; G D PEGRUM; S WOLFF
Journal:  J Clin Pathol       Date:  1965-05       Impact factor: 3.411

3.  The role of human coagulation factors in serum-induced thrombosis.

Authors:  S WESSLER; S M REIMER
Journal:  J Clin Invest       Date:  1960-02       Impact factor: 14.808

4.  Levels of blood-coagulation factors during anticoagulant therapy with phenindione.

Authors:  K W DENSON
Journal:  Br Med J       Date:  1961-04-29

5.  The anticoagulant, antithrombotic and haemorrhagic effect of long-term warfarin on experimental venous and arterial thrombosis in the rat.

Authors:  M MacIomhair; S M Lavelle
Journal:  Ir J Med Sci       Date:  1996 Jul-Sep       Impact factor: 1.568

6.  AN INVESTIGATION OF THE HEMORRHAGIC DIATHESIS IN PATIENTS RECEIVING COUMARIN AND INDANEDIONE ANTICOAGULANTS.

Authors:  C W BAUGH
Journal:  Can Med Assoc J       Date:  1965-01-16       Impact factor: 8.262

7.  Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.

Authors:  A Zivelin; L V Rao; S I Rapaport
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

8.  COUMARIN THERAPY. PROTHROMBIN ACTIVITY AFTER TERMINATION OF TREATMENT.

Authors:  E B REILLY; J R GOODMAN; G F WARNER
Journal:  Calif Med       Date:  1963-10

9.  Pharmacometric modeling to explore 4F-PCC dosing strategies for VKA reversal in patients with INR below 2.

Authors:  Ravi Sarode; Katsuyuki Fukutake; Masahiro Yasaka; Michael A Tortorici; Antoinette Mangione; Marc Pfister; Adam Cuker
Journal:  Blood Adv       Date:  2020-09-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.